Vistagen Therapeutics, Inc. (VTGN) · INSIDERData sourcesSEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago
Public companyVistagen Therapeutics, Inc.
VTGNCIK 0001411685
Price$0.18
1 year-95.6%
Disclosed transactions8
Buys / sells0 / 0
Max Insider Score15
Connections with evidence6
VTGN · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 9 | ASAngelov Angel SChief Medical Officer | VTGNVistagen Therapeutics, Inc. Grant or award | A | — 150.0K sh | May 18, 2026 | May 19, 2026 |
| 9 | AGAdler Reid G.Chief Legal Officer | VTGNVistagen Therapeutics, Inc. Grant or award | A | — 56.2K sh | Apr 7, 2026 | Apr 9, 2026 traded Apr 7, 2026 | +2d | SEC Form 4 | |
| 9 | PSPrince Joshua S.Chief Operating Officer | VTGNVistagen Therapeutics, Inc. Grant or award | A | — 56.2K sh | Apr 7, 2026 | Apr 9, 2026 traded Apr 7, 2026 | +2d | SEC Form 4 | |
| 9 | TBTressler Nick B.Chief Financial Officer | VTGNVistagen Therapeutics, Inc. Grant or award | A | — 75.0K sh | Apr 7, 2026 | Apr 9, 2026 traded Apr 7, 2026 | +2d | SEC Form 4 | |
| 9 | AGAdler Reid G.Chief Legal Officer | VTGNVistagen Therapeutics, Inc. Grant or award | A | — 18.8K sh | Apr 7, 2026 | Apr 9, 2026 traded Apr 7, 2026 | +2d | SEC Form 4 | |
| 9 | CSCote Elissa S.Chief Corp Development Officer | VTGNVistagen Therapeutics, Inc. Grant or award | A | — 75.0K sh | Apr 7, 2026 | Apr 9, 2026 traded Apr 7, 2026 | +2d | SEC Form 4 | |
| 9 | PSPrince Joshua S.Chief Operating Officer | VTGNVistagen Therapeutics, Inc. Grant or award | A | — 18.8K sh | Apr 7, 2026 | Apr 9, 2026 traded Apr 7, 2026 | +2d | SEC Form 4 | |
| 15 | TBTressler Nick B.Chief Financial Officer | VTGNVistagen Therapeutics, Inc. Grant or award | A | — 150.0K sh | Dec 1, 2025 | Dec 4, 2025 traded Dec 1, 2025 | +3d | SEC Form 4 | |
Chief Legal Officer · Apr 9, 2026